Literature DB >> 34519979

Large-Scale Expansion of Umbilical Cord Mesenchymal Stem Cells with Microcarrier Tablets in Bioreactor.

Huanye Xu1, Zhongxiao Cong1, Yuanyuan Zhang1, Wei Liu1, Xiaojun Yan2, Yanan Du3.   

Abstract

Mesenchymal stem cells show great potential in tissue engineering and cell-based therapies. This protocol demonstrates the use of 3D TableTrix® microcarrier tablets for large-scale manufacturing of human umbilical cord mesenchymal stem cells (hUCMSCs) in a 5-L stirred tank bioreactor. 3D TableTrix® microcarrier tablets readily disperse into tens of thousands of porous microcarriers to simplify cell seeding, and 3D FloTrix® vivaSPIN bioreactor could automate, monitor, and control the entire culture process. 3D TableTrix® microcarriers could also be fully dissolved upon adding dissolution reagent to gently harvest the expanded cells at a high recovery rate. With this protocol, more than 109 cells could be produced in a 5-L bioreactor.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  3D cell culture; Bioreactor; Dissolvable microcarrier; Large-scale expansion; Mesenchymal stem cells

Mesh:

Substances:

Year:  2022        PMID: 34519979     DOI: 10.1007/7651_2021_425

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures.

Authors:  Alan Tin-Lun Lam; Alison P Lee; Premkumar Jayaraman; Kah Yong Tan; Deepak Raghothaman; Hsueh Lee Lim; He Cheng; Lihan Zhou; Andy Hee-Meng Tan; Shaul Reuveny; Steve Oh
Journal:  Stem Cell Res       Date:  2021-02-26       Impact factor: 2.020

Review 2.  Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy.

Authors:  Tan Li; Mingxu Xia; Yuanyuan Gao; Yanting Chen; Yun Xu
Journal:  Expert Opin Biol Ther       Date:  2015-06-12       Impact factor: 4.388

Review 3.  Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair.

Authors:  Siqi Yin; Cheng Ji; Peipei Wu; Can Jin; Hui Qian
Journal:  Am J Transl Res       Date:  2019-03-15       Impact factor: 4.060

Review 4.  Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy.

Authors:  Dah-Ching Ding; Yu-Hsun Chang; Woei-Cherng Shyu; Shinn-Zong Lin
Journal:  Cell Transplant       Date:  2015-01-23       Impact factor: 4.064

5.  Dispersible and Dissolvable Porous Microcarrier Tablets Enable Efficient Large-Scale Human Mesenchymal Stem Cell Expansion.

Authors:  Xiaojun Yan; Kun Zhang; Yanping Yang; Dongkai Deng; Cheng Lyu; Huanye Xu; Wei Liu; Yanan Du
Journal:  Tissue Eng Part C Methods       Date:  2020-05-11       Impact factor: 3.056

6.  Induction of CD14 Expression and Differentiation to Monocytes or Mature Macrophages in Promyelocytic Cell Lines: New Approach.

Authors:  Fatemeh Zamani; Fateme Zare Shahneh; Leili Aghebati-Maleki; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-08-20

Review 7.  Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment.

Authors:  Yoda Yaghoubi; AliAkbar Movassaghpour; Majid Zamani; Mehdi Talebi; Amir Mehdizadeh; Mehdi Yousefi
Journal:  Life Sci       Date:  2019-08-05       Impact factor: 5.037

8.  Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads.

Authors:  I Kassis; L Zangi; R Rivkin; L Levdansky; S Samuel; G Marx; R Gorodetsky
Journal:  Bone Marrow Transplant       Date:  2006-05       Impact factor: 5.483

Review 9.  Cartilage repair by mesenchymal stem cells: Clinical trial update and perspectives.

Authors:  Wayne Yuk-Wai Lee; Bin Wang
Journal:  J Orthop Translat       Date:  2017-04-09       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.